Mercury Pharmaceuticals Limited: UK Public Sector Contracts Won & Awards
Large organisation·Companies House: Private Limited Company·London, United Kingdom.·Greater London·Main market: Pharmaceutical products
Official UK PPONPHGH-5788-VVDLCompanies House02619880 ↗ · Active
Where they wini
i
95 awards (94 for a named lot, 99%, 1 for a whole procedure with no lot named) · top CPV classes, shares of all 95 awards. An award may cover more than one class.
3360 Pharmaceutical products93 awards · 98% · 92 awards naming a lot + 1 whole-procedure awards3369 Various medicinal products2 awards · 2% · awards naming a loti
i
Where their buyers arei
i
ITL1 region of the buyer office · known for 68 of 68 awarded procedures · each procedure counts once
Bidding recordi
i
Procurement Act 2023 award notices name every bidder · 9 notices name this supplier, covering 13 lots since 6 Oct 2025 · observed bids, not an estimate
i
i
i
| Notice | Authority | Outcome | Bidders | Published |
|---|---|---|---|---|
| NHS National Generic Pharmaceuticals - Wave 16a | NHS England | appointedall 3 lots bid for | 125 | 9 Oct 2026 |
| NHS National Generics Pharmaceuticals - Supply Chain Resilience | NHS England | not appointed | 41 | 6 Jul 2026 |
| NHS National Branded Interim - 1 June 2026 | NHS England | appointed | 53 | 22 May 2026 |
| NHS National Framework for Transition Products (Nintedanib and Dalbavancin) | NHS England | not appointed | 14 | 24 Apr 2026 |
| NHS National Generic Pharmaceuticals - Wave 15c | NHS England | appointedall 2 lots bid for | 118 | 26 Feb 2026 |
| NHS National Framework Agreement for Omalizumab | NHS England | appointed | 3 | 30 Dec 2025 |
| NHS National Framework for Generics Housekeeping | NHS England | appointedall 2 lots bid for | 53 | 22 Dec 2025 |
| NHS National Framework for Golimumab Injection | NHS England | appointed | 3 | 17 Oct 2025 |
| NHS National Framework for Medical Retinal Vascular Treatments - 1 December 2025 | NHS England | undecided | 17 | 6 Oct 2025 |
Bidder names come from Procurement Act 2023 award notices, which list every bidder (from 2025). Older notices name no bidders, so earlier contests do not appear here. Latest ten notices shown.
Who they sell toi
i
Authorities named on this supplier’s published awards · ranked by distinct procedures · a framework or DPS adds one award record per appointed supplier
i
NHS & health92%(87 awards)
87 of 95 awards are NHS & health (92%).Type not classified8%(8 awards)
8 of 95 awards are Type not classified (8%).
| Authority | Procedures | Share | Award records | Last activity |
|---|---|---|---|---|
| NHS England | 29 | 42.6% | 46 | 27 Aug 2026 |
| NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) | 15 | 22.1% | 15 | 17 Sept 2026 |
| The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS") | 12 | 17.6% | 28 | 9 Apr 2026 |
| The NHS Commissioning Board (operating under the name of NHS England) | 3 | 4.4% | 5 | 30 Nov 2021 |
| ATAMIS LTD | 3 | 4.4% | 3 | 7 Jul 2023 |
| Regional Business Services Organisation Procurement and Logistics Service | 2 | 2.9% | 7 | 23 Jun 2026 |
| Department of Health & Social Care | 2 | 2.9% | 2 | 11 Nov 2020 |
| eTenderwales | 1 | 1.5% | 1 | 17 Jun 2025 |
Share = of the 68 procedures with an award naming this supplier. Last activity = award date, or notice publication when no award date was published.
Contracts endingi
i
99 of 108 awards carry an end date, 33 estimated from the duration · not a retender forecast
| Contract | Ends | Published value |
|---|---|---|
| Lanreotide Injection Prefilled Syringes (unbundled - without homecare) | 3 Jan 2027 estimated | £1,324,548 ceiling |
| Lanreotide Injection Prefilled Syringes (bundled - with homecare) | 3 Jan 2027 estimated | £681,188 ceiling |
| Generic Drugs - Tablets & Capsules | 31 Jan 2027 | £362,586 |
| Generic Anti-Infective Drugs | 31 Jan 2027 | £917,823 |
| Wave 15a - Hospital Only Products (DNW & DLN regions) | 31 Jan 2027 | £1 ceiling |
| Hospital Only Products | 31 Jan 2027 | £1 ceiling |
| Wave 15b - Hospital Only (Housekeeping) All regions | 31 Jan 2027 | £1 ceiling |
| Cancer Medicines (Group 2) | 31 Jan 2027 | £18,207,081 ceiling |
| Cytokine Modulators (Golimumab, Tocilizumab, and Etanercept) | 28 Feb 2027 | £26,539,272 ceiling |
| Cytokine Modulators (Omalizumab) | 28 Feb 2027 | £9,253,091 ceiling |
Soonest 10 of 35.
Recent awards
Latest 30 of 95 award records naming this supplier
Contracts Finder adds 13 more procedures won by this supplier, mostly below the Find a Tender threshold or from before 2025. Each is counted once beside any Find a Tender copy; they are in the totals, not in this list.
About this data
- One profile per supplier. Built from award and contract notices that name this supplier; different spellings and registration numbers of the same company are merged into this profile.
- Values are published values. The table mirrors what the notice published: framework ceilings and joint awards are labelled and never counted as this supplier's money, and † marks a value taken from the contract notice when the award published none. Only awards made to this supplier alone count towards its value, excluding VAT. It is not turnover.
- Regions in the buyer chart describe the buyer office, not where the work is delivered or the supplier’s registered address.
- Contract end dates. Published on 66 of 108 awards, estimated from the published duration on 33 more (marked “estimated”); those feed “Contracts ending”. Published values in that list come from either source; Contracts Finder figures are shown as published and stay out of this profile’s money totals.
- Source. Official UK public procurement notices (Find a Tender and Contracts Finder), reused under the Open Government Licence v3.0, updated through the day and rebuilt nightly. Not every figure uses both feeds, and each one shows how many records it rests on: see the methodology. Spotted something wrong? Tell us.